[1]FOLKMAN J. Angiogenesis and apoptosis[J]. Semin Cancer Biol, 2003,13(2):159?167.

[2]HANAHAN D, BERGERS G, BERGSLAND E. Less is more, regularly:metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice[J]. J Clin Invest, 2000,105(8):1045?1047.

[3]PICCART?GEBHARTM J. Mathematics and oncology: a match for life[J]? J Clin Oncol, 2003,21(8):1425?1428.

[4]BERTOLINI F, PAUL S, MANCUSO P, et al. Maximum tolerable dose and low?dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells[J]. Cancer Res, 2003,63(5):4342?4346.

[6]周晓彬,纪新强,徐莉. 医用统计学软件PPMS 1.5的组成和应用特点[J]. 齐鲁医学杂志, 2009,24(1):29?32.

[6]HAHNFELDT P, FOLKMAN J, HLATKY L. Minimizing long?term tumor burden: the logic for metronomic chemotherapeutic dosing and its anti?angiogenic basis[J]. Theor Biol, 2003,220(4): 545?554.

[7]MILLER K D, SWEENEY C J, SLEDGE G W. Redefining the target:chemotherapeutics as antiangiogenics[J]. J Clin Oncol, 2001,19(4):1195?1206.

[8]KLEMENT G, HUANG P, MAYER B, et al. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti?VEGFR?2 antibody in multidrug?resistant human breast cancer xenografts [J]. Clin Cancer Res, 2002,8(1)：221?232.

[9]NGUYEN M, SHING Y, FOLKMAN J. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane[J]. Microvasc Res, 1994,47:31?40.

[10]MOSMANN T. Rapid colorimetric assay for celluar growth and survival: application to proferation and cytotoxicity assays[J]. J Immunol Methods, 1983,65:55?63.

[11]王延涛,沈方臻,侯继院. 低剂量顺铂并IFN?α对小鼠移植性肝癌血管生成影响[J]. 青岛大学医学院学报, 2008,44(1):37.

[12]侯继院,沈方臻,王延涛,等. 顺铂低剂量节律化疗抑制小鼠H22肝癌血管生成观察[J]. 齐鲁医学杂志, 2008,23(2):95.

精品学习网 医药卫生栏目